Company profile: ABclonal
1.1 - Company Overview
Company description
- Provider of global antibody and molecular enzyme reagents, offering antibodies for research and diagnostic applications; proteins, peptides, ELISA kits to detect and quantify proteins and other molecules; molecular biology reagents; and next-generation sequencing products and services for genetic analysis.
Products and services
- Next-generation Sequencing: ABclonal supplies genetic-analysis-focused services and products related to next-generation sequencing for genetic analysis, supporting research projects in laboratories
- Antibody: ABclonal delivers research-grade antibodies used for various research and diagnostic applications, supporting experiments and testing in diverse laboratory contexts worldwide
- ELISA: ABclonal offers kit-based ELISA products for detecting and quantifying proteins and other molecules, enabling measurement workflows in research settings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ABclonal
Rebus Biosystems
HQ: United States
Website
- Description: Provider of spatial omics tools: Rebus Esper for single-cell data at subcellular resolution; Esper High Fidelity assay for spatial transcriptomics (up to 30 custom genes without barcoding or enzymatic amplification); Esper High Plex assay enabling analysis of 1230 gene panels; SAO microscopy enhancing resolution without sacrificing throughput; plus the Esper Service Program providing processed gene images and a spatially annotated CellxFeature matrix.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rebus Biosystems company profile →
GlycoFi
HQ: United States
Website
- Description: Provider of biotherapeutic development based on glycan optimization technology and a yeast-based glycosylation protein manufacturing process, aiming to build its own pipeline of therapeutic proteins and partner with other drug-makers to develop products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GlycoFi company profile →
SQZ Biotech
HQ: United States
Website
- Description: Provider of cell engineering technology designed to deliver a diverse set of materials into patient cells and to develop cellular therapies for multiple indications using proprietary CellSqueeze technology, advanced through internal research programs and external partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SQZ Biotech company profile →
Bio-Techne
HQ: United States
Website
- Description: Provider of tools for life science research, therapeutic manufacturing, and clinical diagnostics, including automated protein analysis (Simple Western), automated ELISA (Ella), bead-based multiplex assays (Luminex), non-viral gene transfer (TcBuster), recombinant antibodies, and custom bioactive compound libraries (Tocriscreen PRO) for research, drug discovery, and cell engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-Techne company profile →
Olink
HQ: Sweden
Website
- Description: Provider of proteomics platforms and services for biomolecular analysis, including Olink Explore for high-throughput protein biomarker discovery (3072 assays, minimal sample volume), Olink Target 96/48 qPCR panels for disease- or biology-focused studies, Olink Flex customizable panels (up to 21 human proteins), the Olink Signature benchtop readout instrument, and Olink Analysis Service for Target and Explore.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Olink company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ABclonal
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ABclonal
2.2 - Growth funds investing in similar companies to ABclonal
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ABclonal
4.2 - Public trading comparable groups for ABclonal
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →